Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a public biotech company developing new ...
A multi-omics study reveals that impaired branched-chain amino acid (BCAA) catabolism is a key driver of sarcopenia, ...
Researchers from Tokyo Metropolitan University have developed a way to treat age-related muscular atrophy using regenerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback